Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
- PMID: 31094181
- DOI: 10.26442/00403660.2019.02.000122
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
Abstract
The article presents an update of the role of non-alcoholic fatty liver disease (NAFLD) in cardiometabolic diseases and events: arterial hypertension and components of the metabolic syndrome. A review of NAFLD modern pharmacotherapy has been conducted. Particular attention is paid to the place of ursodeoxycholic acid in the complex treatment of NAFLD.
Keywords: arterial hypertension; insulin resistance; non-alcoholic fatty liver disease; ursodeoxycholic acid.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical